API/ESCMID UpToDate COVID-19 - Wednesday 17 June, 20:00 CEST

Join an inter-continental faculty for the upcoming live online symposium event 'UpToDate COVID-19', being hosted by the Asociación Panamericana de Infectiología (API).

ESCMID President Maurizio Sanguinetti and Immediate Past-President Jesús Rodríguez-Baño will join the conversation on Clinical and diagnostic aspects of COVID-19.

View the Programme flyer here.

› Read more

ECCVID: call for session proposals

ISID/ESCMID Fellowships Open!

ESCMID and ISID (International Society for Infectious Diseases) jointly sponsor two fellowships per year to perform multidisciplinary clinical and laboratory training abroad. This particular fellowship is intended for applicants from outside Europe, wishing to come to Europe for their fellowship, or for European applicants going overseas. Young colleagues are invited to learn from experienced specialists and to take home new ideas and processes that help them improve their clinical or laboratory practice.

You can apply for this fellowship on the ISID website here.

Applications are open until June 21, 2020

› Read more

EUCAST panels of phenotypically defined strains available

EUCAST in collaboration with CCUG (the Culture Collection of the University of Gothenburg, Sweden), and EUCAST NACs, make panels of organisms with phenotypically well characterized levels of susceptibility generally available. MIC-values were determined with reference broth micro-dilution on several occasions before and after freeze drying. Each panel will contain 5 - 25 strains of which a few strains have MICs representative of the wild type of the species, and others with typical resistance mechanisms and phenotypically reproducible levels of susceptibility. Each panel will highlight a difficult area of susceptibility testing. They will be useful for

1. laboratories aiming to validate the accuracy of their AST methods,
2. for validating the quality of commercial material intended for susceptibility testing (the MIC-value or the correct categorisation of S, I and R)
3. developers of antimicrobials and
4. developers of AST methods.

The first panel, consisting of 10 isolates of Streptococcus pneumoniae with varying levels of betalactam susceptibility, was recently made available (June, 2020).

Streptococcus pneumoniae – selection of strains based on varying levels of betalactam susceptibility.

› Read more

Elections of Study Group Executive Committees

Elections results have been announced for the following Study Groups: ESGAP, ESGHAMI, ESGARS, ESGCD, EVASG, ESGFOR, EPASG, EFISG, ESGITM, ESGPHM, EFWISG, ESGBOR, ESGCP, ESGIB, ESGIE, ESGMD and ESGS. Elections have closed for ESGCIP, ESGREV, ESGMYC and ESGLI; the respective Election Committees are currently reviewing the results of the vote.

Special elections to replace a member of the executive committee have been opened for ESGAI; the election committee has reviewed nominations and opened elections. To participate in the election process, log in to my.escmid.org with your ESCMID credentials and click on the “Study Group Elections” icon. Only members with a valid ESCMID membership can take part in the election process; to be able to vote, please be sure to renew immediately your ESCMID membership, should it expire in the coming days.
Deadline to vote: 24 June 2020. 

For any question, contact science@escmid.org

› Read more

CMI highlights: Risk factors for disease progression in mild to moderate COVID-19 patients– a multi-center observational study

The present study aimed at investigating the risk factors for disease progression in mild to moderate cases of COVID-19, through a cohort study which included 1007 mild to moderate cases with COVID-19 from 3 hospitals in Wuhan. After a follow up of 28 days, a panel of risk factors for disease progression in mild to moderate cases with COVID-19 was identified, among which increased age, male sex, presence of hypertension, diabetes, but also chronic pulmonary and coronary artery diseases.

› Read more